论文部分内容阅读
反复呼吸道感染(RRI)是儿科常见病、多发病,除呼吸道局部防御机能降低外,主要是由于机体细胞免疫功能低下和体液免疫功能紊乱所致.我们观察了69例反复呼吸道感染患儿经唯尔本注射液与黄芪精口服液联合治疗半年后的临床疗效,并监测了部分患儿治疗前后的免疫学指标.现将观察结果总结如下.1 资料与方法1.1 一般资料 69例反复呼吸道感染患儿选自我院儿童哮喘门诊及部分住院患儿,均符合“反复呼吸道感染的诊断标准”.其中男38例,女31例,年龄13个月~8岁,平均4.6岁.1.2 治疗方法 (1)唯尔本注射液:0.5mg/支每次肌注0.5mg,2次/周,10周为一疗程,见效后间歇8周,再肌注第二个疗程.(2)黄芪精口服液:10ml/支,每次口服5-10ml,每日2次,连服2个月为一疗程,见效后间歇2个月,再服用第二疗程.
Repeated respiratory infections (RRI) is a common pediatric disease, frequently-occurring disease, in addition to local respiratory defensive function decreased, mainly due to cellular immune dysfunction and humoral immune dysfunction caused by we observed 69 cases of children with recurrent respiratory tract infection only Erben injection combined with astragalin oral liquid after six months of clinical efficacy and monitoring of some children before and after treatment of immunological indicators are summarized below observations.1 Materials and Methods 1.1 General Information 69 cases of recurrent respiratory tract infection Children selected from our hospital children asthma clinic and some inpatients, are in line with “recurrent respiratory tract infection diagnostic criteria.” There were 38 males and 31 females, aged 13 months to 8 years, an average of 4.6 years of age .1.2 treatment (1 ) Wolben injection: 0.5mg / support intramuscular injection of 0.5mg, 2 times / week, 10 weeks for a course of treatment, effective intermittent for 8 weeks and then intramuscular injection of the second course. (2) Astragalus extract : 10ml / support, each oral 5-10ml, 2 times a day, and even served 2 months as a course of treatment, effective intermittent 2 months, then take the second course of treatment.